Monitoring heart function in congenital heart disease
Part of Genetic & congenital, Heart & circulation clinical trials.
This study tests a new non-invasive device called UltraTrac that measures how well the heart pumps blood in people with congenital heart disease. It will be used during standard heart procedures or intensive care stays to see if it works as well as current methods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 0 and 80 years old.
- You must weigh at least 2 kg (about 4.5 pounds).
- You must have a congenital heart defect (any type).
- You must be scheduled for a heart catheterization, heart MRI, or admitted to the cardiac ICU.
- You cannot be pregnant, a prisoner, or an adult unable to give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how blood flow and heart rhythm may affect exercise ability in people born with certain heart defects that have been repaired or treated. It uses a specialized heart MRI and ultrasound measurements to better understand these problems and their causes.
This study tests an investigational medical device (the UltraTrac) worn on the skin while children undergo a routine heart catheterization. The device aims to improve monitoring during the procedure and may help guide care more safely.
This study tests a device called UltraTrac that checks your heart and lung health without needles or invasive procedures. It may help doctors better monitor conditions like heart failure or asthma in the future.
This trial is testing a way to help doctors assess babies and children with congenital heart disease and heart failure before placing a temporary heart support pump. It may help improve planning by using heart scans to decide who needs support and how to prepare.
This trial tests a new, non-invasive way to create detailed 3D maps of the heart's electrical activity in people with congenital heart disease. It aims to help guide procedures like heart catheterization or device implantation, potentially making them safer and more personalized.
This study uses wearable devices like smartwatches or wristbands to monitor your heart's output (how much blood it pumps) during daily activities and exercise. The goal is to see if these devices can reliably measure heart function without invasive tests, which could help manage heart conditions more easily.
Hear when a new Congenital Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.